239
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
Mizoribine (MZR)
Cyclophosphamide (CTX)
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Tongren Hospital, Capital Medical University, Beijing
China-Japan Friendship Hospital, Beijing
Chinese PLA General Hospital, Beijing
The Third Affiliated Hospital of the Third Military Medical University (Daping Hospital), Chongqing
Fuzhou General Hospital of Nanjing Military Region, Fuzhou
The first Affiliated Hospital of Fujian Medical University, Fuzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Affiliated Hospital of Guilin Medical University, Guilin
The First Affiliated Hospital of Guangxi Medical University, Nanning
The Third Hospital of Hebei Medical University, Shijiazhuang
Wuxi People's Hospital, Wuxi
The First Affiliated Hospital of Nanchang University, Nanchang
The First Hospital of Jilin University, Changchun
The Second Hospital of Jilin University, Changchun
The First Affiliated Hospital of Dalian Medical University, Dalian
The General Hospital of Shenyang Military Region, Shenyang
Shandong Provincial Hospital, Jinan
The General Hospital of Jinan Military Region, Jinan
The Affilited Hospital of Qingdao University, Qingdao
Renji Hospital Shanghai Jiaotong University School of Medical, Shanghai
Xinhua Hospital Shanghai Jiaotong University School of Medical, Shanghai
Zhongshan Hospital Fudan University, Shanghai
The Second Hospital of Shanxi Medical University, Taiyuan
The First Affiliated Hospital of Xi'an Jiaotong University, Xian
West China Hospital of Sichuan University, Chengdu
Kuming General Hospital of Chengdu Military Region, Kunming
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
Asahi Kasei Pharma Corporation
INDUSTRY